In this self-paced e-learning module we will take a look at non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
After completing this pathophysiology and diagnosis e-learning module, you should be able to:
- understand the pathological mechanisms behind NAFLD-NASH
- understand the various means for diagnosis of NAFLD-NASH as well as their advantages and disadvantages
- know what guidelines recommend with regards to screening
This module is created by course director Onno Holleboom (AmsterdamUMC, the Netherlands) and consists of the following topics:
- A multi-system disease
>Insulin resistance
>Lipid metabolism and lipotoxicity
>Inflammation & macrophage activation
>Dysbiosis
>Genetic factors
● NAFLD/NASH symptoms and signs
● Diagnosis
> liver biopsy
> Non-invasive methods
o Biomarkers
o NAFLD Fibrosis Score
o Enhanced liver fibrosis (ELF) test
o Elastography (VCTE, FibroScan, MRE)
o Fibrosis-4 (FIB-4) test
● Screening:
> Who?
> When?
> By whom?
> Barriers to screening
Enjoyed this course? After completing the course you can sign up for updates on the upcoming educational content.